Low muscle mass, density linked to shorter survival in lymphoma

Low muscle mass, density linked to shorter survival in lymphoma

(HealthDay)—The combination of low muscle mass (LMM) and low muscle density (LMD) is associated with shorter survival in patients with diffuse large B-cell lymphoma (DLBCL), according to a study published online March 13 in Leukemia & Lymphoma.

Hánah N. Rier, from Albert Schweitzer Hospital in Dordrecht, Netherlands, and colleagues examined the association between LMM and LMD and survival in with DLBCL. A total of 164 DLBCL patients underwent computed tomography-based measurement of prior to chemo-immunotherapy.

The researchers defined LMM or LMD as a Z-score less than −1, and they were linked to overall and . In 13 percent of DLBCL patients, the coexistence of both LMM and LMD was observed and was significantly associated with shorter overall and progression-free survival (multivariable hazard ratios, 2.42 and 2.16). Patients with LMM and LMD more often did not complete planned treatment (31.8 versus 13.6 percent) and were less likely to achieve a complete response (59.1 versus 81.7 percent).

"Patients with DLBCL have LMM and LMD compared to healthy counterparts. The combination of LMM and LMD is a negative prognostic factor for survival, independent of comorbidities and unfavorable characteristics," the authors write. "This might result in the identification of possible roles for muscle measurements in drug dosing and treatment decision making."

More information: Abstract/Full Text

Copyright © 2020 HealthDay. All rights reserved.

Citation: Low muscle mass, density linked to shorter survival in lymphoma (2020, March 19) retrieved 3 March 2024 from https://medicalxpress.com/news/2020-03-muscle-mass-density-linked-shorter.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Five-year survival less than 40 percent in seniors with DLBCL


Feedback to editors